Why is Boston Scientific Stock Trading Lower On Wednesday?
On Wednesday, Boston Scientific Corporation BSX released the results of the primary endpoint of the ACURATE IDE trial of ACURATE neo2 Aortic Valve System for patients with severe, symptomatic aortic stenosis at risk of open-heart surgery.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
Here is how Boston Scientific (BSX) and Addex Therapeutics Ltd. Sponsored ADR (ADXN) have performed compared to their sector so far this year.
Boston Scientific Profit Falls Even as Demand for Its Heart Products Surges
Boston Scientific (BSX) shares fell Wednesday when the medical equipment manufacturer's third-quarter profit fell and its GAAP earnings per share (EPS) came in short of its guidance.
BSX Q3 Earnings Top, Stock Down in Premarket as Operating Margin Falls
Boston Scientific registers year-over-year improvement in sales, indicating solid market share gains in legacy businesses despite macroeconomic odds.
Boston Scientific Corporation (BSX) Q3 2024 Earnings Call Transcript
Boston Scientific Corporation (NYSE:BSX ) Q3 2024 Earnings Conference Call October 23, 2024 8:00 AM ET Company Participants Jonathan Monson - Senior Vice President, Investor Relations Michael Mahoney - Chairman and Chief Executive Officer Daniel Brennan - Executive Vice President and Chief Financial Officer Kenneth Stein - Senior Vice President, Global Chief Medical Officer Conference Call Participants Robert Marcus - JPMorgan Joanne Wuensch - Citigroup Inc. Lawrence Biegelsen - Wells Fargo Securities Frederick Wise - Stifel, Nicolaus & Company David Roman - Goldman Sachs Patrick Wood - Morgan Stanley Travis Steed - Barclays Bank Danielle Antalffy - UBS Anthony Petrone - Mizuho Group Vijay Kumar - Evercore ISI Matt Miksic - Barclays Joshua Jennings - TD Cowen Matthew O'Brien - Piper Sandler Operator Good morning and welcome to the Boston Scientific Third Quarter 2024 Earnings Call. All participants will be in listen-only mode.
Compared to Estimates, Boston Scientific (BSX) Q3 Earnings: A Look at Key Metrics
The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Boston Scientific (BSX) Surpasses Q3 Earnings and Revenue Estimates
Boston Scientific (BSX) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.50 per share a year ago.
Boston Scientific's stock climbs on Q3 sales and earnings beat
Medical-products company Boston Scientific reported third-quarter results before market open.
Boston Scientific lifts annual profit forecast on strong demand for heart devices
Boston Scientific raised its annual profit forecast and exceeded Wall Street's estimates for third-quarter profit on Wednesday, driven by robust demand for its heart devices, sending its shares higher 1.1% to $88.94 in premarket trading.
Boston Scientific Earnings, Sales Top Q3 Views; Stock Eyes High
Boston Scientific earnings and sales beat Q3 views early Wednesday. The medtech giant's shares, right at record highs, rose before the open,
Boston Scientific Q3 Earnings Preview
Boston Scientific (NYSE: BSX) is scheduled to report its Q3 2024 results on Wednesday, October 23. We expect the company to report revenues and earnings slightly below the consensus estimates.
